RxDoctor Payments Data

Veronica Lorenzo, MD

Family Medicine · Saginaw, MINPI 1326036815

Payments from drug & device makers

$727in general payments, 2019–2025

Across 48 payments — averaging $15.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$145
  • Novo Nordisk$113
  • Pfizer$70
  • Astellas Pharma US Inc$63
  • AstraZeneca$62
  • Lilly USA, LLC$61
  • plus $210 from 9 others

What the payments were for

  • Food & beverage$727100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$727 in reported general payments places this provider in the 65th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$20,849
Medicare patients
132
Services billed
241

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin123$119,370
OzempicSemaglutide96$103,266
TrulicityDulaglutide87$98,607
EliquisApixaban78$73,154
MounjaroTirzepatide16$28,029
MyrbetriqMirabegron18$15,435
RybelsusSemaglutide15$15,377
Stiolto RespimatTiotropium Br/Olodaterol Hcl16$10,481
Lantus SolostarInsulin Glargine,hum.Rec.Anlog46$7,047
Humalog Kwikpen U-100Insulin Lispro15$6,565
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate18$5,685
Mirabegron ErMirabegron11$5,264
Atorvastatin Calcium349$4,754
Levothyroxine Sodium347$4,522
Metoprolol Succinate205$4,175

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Stiolto Respimat$145$129,851139 claims
Lilly USA, LLCTrulicity, Mounjaro$61$126,636103 claims
Novo NordiskOzempic, Rybelsus$113$118,643111 claims
PfizerEliquis$70$73,15478 claims
Astellas Pharma US IncMyrbetriq$63$15,43518 claims
AbbVieSynthroid$14$2,55820 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Saginaw

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →